Catalog No.
RHN91001
Species reactivity
Human, Mouse, Hamster, Monkey
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
IF: 1:200-1:1000, IHC: 1:200-1:1000, WB: 1:500-1:2000
Target
Lipoma-preferred partner, LIM domain-containing preferred translocation partner in lipoma, LPP
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q93052
Applications
IF, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R4A74
Development of intimin-enriched outer membrane vesicles (OMVs) as a vaccine to control intestinal carriage of Enterohemorrhagic Escherichia coli., PMID:39985970
Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe., PMID:39931677
Development and evaluation of optimized PCR and indirect ELISA for the detection of Morganella morganii in dairy cows., PMID:39886025
Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus., PMID:39852872
A broad spectrum Shigella vaccine based on VirG53-353 multiepitope region produced in a cell-free system., PMID:39805874
A genome-wide meta-analysis reveals shared and population-specific variants for allergic sensitization., PMID:39644933
Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study., PMID:39571557
Immunogenicity and cross-protective efficacy induced by delayed attenuated Salmonella with regulated length of lipopolysaccharide in mice., PMID:39529227
Polarization of the memory B-cell response., PMID:39401326
Constructing a Ready-to-Use mRNA Vaccine Delivery System for the Prevention of Influenza A virus, Utilizing FDA-Approved Raw Materials., PMID:38843459
Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study., PMID:38735684
Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex., PMID:38557908
Construction and Evaluation of an Efficient Live Attenuated Salmonella Choleraesuis Vaccine and Its Ability as a Vaccine Carrier to Deliver Heterologous Antigens., PMID:38543883
An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants., PMID:38184234
Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)., PMID:38169790
LRRC37B is a human modifier of voltage-gated sodium channels and axon excitability in cortical neurons., PMID:38134874
Human super antibody to viral RNA-dependent RNA polymerase produced by a modified Sortase self-cleave-bacteria surface display system., PMID:38110987
Lichen planus pemphigoides induced by anti-PD-1 antibody: A case only involved in oral mucosa with excellent topical treatment efficiency., PMID:37846754
A single immunization with core-shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs., PMID:37819147
Recruitment into antibody prevalence studies: a randomized trial of postcards vs. letters as invitations., PMID:37481522
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial., PMID:37099843
Successful treatment of rare linear lichen planopilaris with Ixekizumab., PMID:37026832
A Novel Shigella O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes., PMID:37017547
Identification and comparison of Chlamydia psittaci, Legionella and Mycoplasma pneumonia infection., PMID:36929690
Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis., PMID:36809058
Study of the Thyroid Profile of Patients with Alopecia., PMID:36769763
Reducing the endotoxic activity or enhancing the vaccine immunogenicity by altering the length of lipid A acyl chain in Salmonella., PMID:36700768
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2., PMID:36683074
IL-17 Expression in the Perifollicular Fibrosis in Biopsies From Lichen Planopilaris., PMID:36197049
The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants., PMID:36181724
Single-cell transcriptome atlas reveals protective characteristics of COVID-19 mRNA vaccine., PMID:36124363
Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade., PMID:36054729
A case of severe nivolumab-induced lichen planus pemphigoides in a child with metastatic spitzoid melanoma., PMID:35882548
Dendritic cells may help differentiate discoid lupus erythematosus alopecia from lichen planopilaris., PMID:35645667
Microenergy acoustic pulse therapy restores urethral wall integrity and continence in a rat model of female stress incontinence., PMID:35451520
Challenges and pitfalls between lichen planus pemphigoides and bullous lichen planus., PMID:35196400
Lichen Planus Pemphigoides Associated With PD-1 and PD-L1 Inhibitors: A Case Series and Review of the Literature., PMID:35120032
Plasma Cell-Predominant Lichen Planopilaris., PMID:35076427
Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague., PMID:34872353
The role of interleukin-17 (IL-17) in the pathogenesis of discoid lupus erythematosus and lichen planopilaris: is immunohistochemistry for IL-17 a promising way to differentiate these entities?, PMID:34530493
A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome., PMID:34439266
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity., PMID:34059617
Association of Human Herpes Virus 6 Infection with Lichen Planopilaris., PMID:33116105
Molecular dynamics simulation and experimental study of the surface-display of SPA protein via Lpp-OmpA system for screening of IgG., PMID:32880759
Therapeutic potential of muscle growth promoters in a stress urinary incontinence model., PMID:32686522
Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab., PMID:32458516
Development of a monoclonal antibody for specific detection of Vibrio parahaemolyticus and analysis of its antigen., PMID:32289368
Extracellular production of recombinant N-glycosylated anti-VEGFR2 monobody in leaky Escherichia coli strain., PMID:31541332
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients., PMID:31501610
Evaluation of the immunogenicity of an omp A and staphylococcal target of RNAIII activating fusion protein displayed on the surface of Escherichia coli., PMID:31437577
For research use only. Not for human or drug use.
